2 Matching Annotations
  1. May 2020
  2. Oct 2017
    1. Blinatumomab is a murine BiTE® antibody construct combining dual specificities for the human pan-B-cell antigen CD19 and the human CD3ε chain of the TCR complex on a single polypeptide chain, with binding affinities of approximately 10−9 M and 10−7 M, respectively

      binding affinity